Share

Bright Minds. Bold City.

Endocrinology’s brightest minds will gather once again in San Francisco from July 12–15 for ENDO 2025. Showcasing groundbreaking research, cutting-edge clinical advances, and abstract discussions on the future of hormone science and care, our signature conference promises a transformative experience for researchers, clinicians, and healthcare leaders alike. While San Francisco sets the stage for ENDO...
Share

Bypass and Beyond: Redefining Roles and Mechanisms of Obesity Treatment at ENDO 2025

Endocrine News talks with the chair and presenters of “Bariatric Surgery and Emerging Medications: Redefining Roles and Mechanisms,”an ENDO 2025 session that analyzes a variety of factors that are impacted by bariatric surgery including postsurgical hypoglycemia, surgery versus pharmacological solutions, as well as a number of molecular mechanisms of the surgery itself. With so many...
Share

Easy Targets: How Endocrine-Disrupting Chemicals Affect Reproductive Endocrinology

Veiga-Lopez_Almudena-cropped-600x676 Endocrine-disrupting chemicals have been implicated in a wide range of poor health outcomes, including infertility and obesity. Endocrine News speaks to Almudena Veiga-Lopez, DVM, PhD, the chair of an upcoming ENDO 2025 symposium on these chemicals’ effects on reproductive organs, which are particularly vulnerable to EDCs. Endocrine-disrupting chemicals are everywhere, and there is seemingly no...
Share

Sriram Gubbi of NIDDK Wins Endocrine Society’s 2025 Endocrine Images Art Competition 

SGubbi headshot for ENDO 2025 “Cosmic Bubble” image features cells from a thyroid cancer subtype  Sriram Gubbi, MD, won the Endocrine Society’s 2025 Endocrine Images Art Competition with his microphotograph of follicular thyroid carcinoma cells titled “The Cosmic Bubble”.   The art competition celebrates the beauty of endocrine science as seen through the lens of a microscope. More than 30 entries...
Share

New Professional Development Workshops Debut at ENDO 2024

What do podcasting, grant writing, microaggressions, and retirement all have in common? They are all topics covered by new Professional Development Workshops at ENDO 2024! When attendees descend on Boston in June for ENDO 2024, they will have the opportunity to participate in a series of workshops that will enhance their visibility in the endocrine...
Share

Advancements from Atumelnant (CRN04894) and Paltusotine Development Programs to Be Presented at ENDO 2024

Five abstracts from Crinetics Pharmaceuticals’s clinical development programs, including four late-breaking abstracts, will be presented at the Endocrine Society’s annual meeting, ENDO 2024, taking place June 1-4, 2024 in Boston – including initial data from a Phase 2 Trial of atumelnant in congenital adrenal hyperplasia (CAH). “This year’s Endocrine Society meeting represents a major milestone for...